Norway

Norgine is working towards full compliance with Pharmaceutical Industry in Norway (LMI) and EFPIA requirements to report payments and transfers of value to healthcare professionals and healthcare organisations.

Please click on the following links to have a view of the recent transfers of value and our methodology for collecting the same.

Should you have any query related to the reported transfers of value, please contact us via contact details as listed towards the end of our methodology note.

Transfers of value: 2020, 2019, 2018

Methodology note: 2020, 2019, 2018

Patient Organisations/Donations: no interactions in 2020, 2019 or 2018

Norgine acquired Azanta in March 2020. See Azanta’s transfers of value for the years 2018 and 2019 here and click here for the methodology notes